PEAK6’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.95M Sell
159,200
-960,100
-86% -$44.5M 0.01% 672
2026
Q2
$47.8M Buy
1,119,300
+1,053,100
+1,591% +$57.2M 0.1% 175
2026
Q1
$4.15M Buy
66,200
+24,300
+58% +$1.94M 0.01% 992
2025
Q4
$4M Sell
41,900
-5,100
-11% -$500K 0.01% 1056
2025
Q3
$4.59M Buy
47,000
+3,500
+8% +$362K 0.01% 1070
2025
Q2
$4.67M Sell
43,500
-56,700
-57% -$5.74M 0.01% 1001
2025
Q1
$10.1M Buy
100,200
+34,100
+52% +$3.43M 0.02% 601
2024
Q4
$5.9M Buy
+66,100
New +$5.82M 0.01% 818

Other funds holding BSX

PEAK6's BSX Position: Q3 2026 in Review

PEAK6 reduced its Boston Scientific (BSX) stake by 82% in Q3 2026, selling an estimated $26.1M and leaving 120,902 shares worth $5.28M. The position accounts for 0.01% of the portfolio, ranked #774.

PEAK6 first reported a position in BSX in Q4 2025 and has held it in 4 quarters since. The position peaked at $29.2M in Q2 2026. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • PEAK6 held 120,902 shares of Boston Scientific worth $5.28M as of Q3 2026.
  • PEAK6 sold 562,906 Boston Scientific shares in Q3 2026, an estimated $26.1M.
  • Boston Scientific made up 0.01% of PEAK6's portfolio in Q3 2026, its #774 holding.
  • PEAK6 first reported a position in Boston Scientific in Q4 2025 and has held it in 4 quarters since.
  • PEAK6's Boston Scientific position peaked at $29.2M in Q2 2026.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.